NICHOLAS GONZALEZ, M.D. graduated from Brown University in Providence, Rhode Island, Phi Beta Kappa, Magna Cum Laude, with a Degree in English Literature. He subsequently worked as a Journalist, first at Time Inc., before pursuing pre-medical studies at Columbia University in New York City. He then received his Medical Degree from Cornell University Medical College, New York City, in 1983.
During a postgraduate Immunology Fellowship under Robert A. Good, M.D., Ph.D., considered the father of modern Immunology and for years President of Sloan-Kettering, he completed a research study evaluating the Kelley Nutritional Therapy in the treatment of advanced cancer.
Since 1987, Dr. Gonzalez has been in private practice in New York City, treating patients diagnosed with cancer and other serious degenerative illnesses. His nutritional research has received substantial financial support from the Procter & Gamble Company and Nestec, Inc. (Nestlé). Results from a pilot study published in 1999 in the journal "Nutrition and Cancer" described the most positive data in the medical literature for pancreatic cancer.
Dr. Gonzalez has released three books. The first, The Trophoblast and the Origins of Cancer, discusses from a contemporary perspective John Beard, D.Sc., who 100 years ago first suggested an anti-cancer effect for pancreatic enzymes. The second in the series, One Man Alone, presents the results of Dr. Gonzalez's five-year investigation of William Donald Kelley, D.D.S., completed under the direction of Dr. Good. The third, What Went Wrong, documents Dr. Gonzalez's battle to have his therapy properly tested in an NCI Clinical Study. His books can be ordered through the website www.newspringpress.com.
Dr. Gonzalez may be contacted at his clinic in New York City by phone 212-213-3337, fax 212-213-3414 and website www.dr-gonzalez.com.
For his lecture, Dr. Gonzalez will present a series of patients with advanced cancer who have experienced long-term survival and disease regression under his care. He will speak on The Trophoblast & The Enzyme Treatment Of Cancer.